Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances

KJJ Cheung, SP Shah, C Steidl… - Blood, The Journal …, 2009 - ashpublications.org
KJJ Cheung, SP Shah, C Steidl, N Johnson, T Relander, A Telenius, B Lai, KP Murphy
Blood, The Journal of the American Society of Hematology, 2009ashpublications.org
The secondary genetic events associated with follicular lymphoma (FL) progression are not
well defined. We applied genome-wide BAC array comparative genomic hybridization to
106 diagnostic biopsies of FL to characterize regional genomic imbalances. Using an
analytical approach that defined regions of copy number change as intersections between
visual annotations and a Hidden Markov model–based algorithm, we identified 71 regional
alterations that were recurrent in at least 10% of cases. These ranged in size from …
Abstract
The secondary genetic events associated with follicular lymphoma (FL) progression are not well defined. We applied genome-wide BAC array comparative genomic hybridization to 106 diagnostic biopsies of FL to characterize regional genomic imbalances. Using an analytical approach that defined regions of copy number change as intersections between visual annotations and a Hidden Markov model–based algorithm, we identified 71 regional alterations that were recurrent in at least 10% of cases. These ranged in size from approximately 200 kb to 44 Mb, affecting chromosomes 1, 5, 6, 7, 8, 10, 12, 17, 18, 19, and 22. We also demonstrated by cluster analysis that 46.2% of the 106 cases could be sub-grouped based on the presence of +1q, +6p/6q−, +7, or +18. Survival analysis showed that 21 of the 71 regions correlated significantly with inferior overall survival (OS). Of these 21 regions, 16 were independent predictors of OS using a multivariate Cox model that included the international prognostic index (IPI) score. Two of these 16 regions (1p36.22-p36.33 and 6q21-q24.3) were also predictors of transformation risk and independent of IPI. These prognostic features may be useful to identify high-risk patients as candidates for risk-adapted therapies.
ashpublications.org